Rats fed a galactose-rich diet have been used for several years as a model for diabetes to study, particularly in the eye, the effects of excess blood hexoses. This study sought to determine the utility of galactosemia as a model for oxidative stress in extraocular tissues by examining biomarkers of oxidative stress in galactose-fed rats and experimentallyinduced diabetic rats. Sprague-Dawley rats were divided into four groups: experimental control; streptozotocin-induced diabetic; insulin-treated diabetic; and galactose-fed. The rats were maintained on these regimens for 30 days, at which point the activities of catalase, glutathione peroxidase, glutathione reductase, and superoxide dismutase, as well as levels of lipid peroxidation and reduced and oxidized glutathione were determined in heart, liver, and kidney. This study indicates that while there are some similarities between galactosemic and diabetic rats in these measured indices of oxidative stress (hepatic catalase activity levels and hepatic and renal levels of oxidized glutathione in both diabetic and galactosemic rats were significantly decreased when compared to normal), overall the galactosemic rat model is not closely parallel to the diabetic rat model in extra-ocular tissues. In addition, several effects of diabetes (increased hepatic glutathione peroxidase activity, increased superoxide dismutase activity in kidney and heart, decreased renal and increased cardiac catalase activity) were not mimicked in galactosemic rats, and glutathione concentration in both liver and heart was affected in opposite ways in diabetic rats and galactose-fed rats. Insulin treatment reversed/prevented the activity changes in renal and cardiac superoxide dismutase, renal and cardiac catalase, and hepatic glutathione peroxidase as well as the hepatic changes in lipid peroxidation and reduced and oxidized glutathione, and the increase in cardiac glutathione. Thus, prudence should be exercised in the use of experimentally galactosemic rats as a model for diabetes until the correspondence of the models has been more fully characterized.
Rats fed a galactose-rich diet have been used for several years as a model for diabetes to study, particularly in the eye, the effects of excess blood hexoses. This study sought to determine the utility of galactosemia as a model for oxidative stress in extraocular tissues by examining biomarkers of oxidative stress in galactose-fed rats and experimentallyinduced diabetic rats. Sprague-Dawley rats were divided into four groups: experimental control; streptozotocin-induced diabetic; insulin-treated diabetic; and galactose-fed. The rats were maintained on these regimens for 30 days, at which point the activities of catalase, glutathione peroxidase, glutathione reductase, and superoxide dismutase, as well as levels of lipid peroxidation and reduced and oxidized glutathione were determined in heart, liver, and kidney. This study indicates that while there are some similarities between galactosemic and diabetic rats in these measured indices of oxidative stress (hepatic catalase activity levels and hepatic and renal levels of oxidized glutathione in both diabetic and galactosemic rats were significantly decreased when compared to normal), overall the galactosemic rat model is not closely parallel to the diabetic rat model in extra-ocular tissues. In addition, several effects of diabetes (increased hepatic glutathione peroxidase activity, increased superoxide dismutase activity in kidney and heart, decreased renal and increased cardiac catalase activity) were not mimicked in galactosemic rats, and glutathione concentration in both liver and heart was affected in opposite ways in diabetic rats and galactose-fed rats. (Fig. 1) . Hepatic and renal levels of GSSG were significantly diminished compared to normal in both diabetic and galactosemic rats (Fig. 2) .
However, several effects of diabetes (increased glutathione peroxidase activity in liver, increased superoxide dismutase activity in kidney and heart, decreased renal and increased cardiac catalase activity, and decreased renal glutathione reductase activity, Fig. 1 animals than in control rats). Curiously, GSH concentration in both liver and heart was affected in opposite ways in diabetic rats and galactose-fed rats (Fig. 2) . Insulin treatment reversed/prevented the activity changes in renal and cardiac superoxide dismutase, renal and cardiac catalase, and hepatic glutathione peroxidase (Fig. 1) . Interestingly, renal glutathione reductase after insulin administration was decreased below the levels in normal and untreated diabetic rats. As Figure 2 shows, insulin treatment of diabetic rats reversed/ prevented the hepatic changes in TBARS, GSH and GSSG as well as the increase in cardiac GSH. Effects of 30 days of streptozotocin-induced diabetes, insulin-treated diabetes, and 50% galactose diet on concentrations of thiobarbituric acid reactive substances (TBARS), reduced glutathione (GSH) and oxidized glutathione (GSSG) in liver, kidney, and heart. Values represent means s.e.m. of 6 to 15 animals per group. *Significantly different from normal control, p < 0.05.
DISCUSSION
Experimentally galactosemic animals have proven to be a productive model for the study of diabetic retinopathy, extensive studies having shown that the effects of high blood hexoses accurately mimic the morphological lesions of DM in the retina. [11'211 Galactose, flooding into the retinal tissue in excess, initiates non-enzymatic glycation and enters into the polyol pathway to generate free radicals and induce oxidative damage, as well as activating protein kinase C and other diabetes-like abnormalities. [7, Further, therapeutics research has found this model to be useful in determining the utility of experimental drugs in controlling this exaggerated polyol pathway. I81 While antioxidants do not promise a cure for chronic complications of DM, many studies [26] [27] [28] [29] [30] [31] [32] have shown they have some success in ameliorating these complications in vitro. Some researchers have sought to utilize the experimentally galactosemic model for research into antioxidant therapies in the eye, [9'33] a viable strategy since previous research has so clearly shown the utility of this model in this tissue. However, galactosemic retinopathy does not always respond to treatment in the same way that diabetic rats do. [25] The elegance of this model, its ability to isolate high blood hexoses and the sequelae of this hyperhexosemia from the other metabolic imbalances found in [8, 36, 37] as well as examining specific cellular and molecular indices.
In conclusion, in light of the overarching divergence of biomarkers of oxidative stress between the models of the diabetic animal and the galactosemic animal, we agree with previous studies I381 that urge caution in the use of this model in studies of hyperglycemia as seen in DM.
